Is Colgate-Palmolive Company (CL) the Best Skincare Stock to Buy According to Hedge Funds?

Insider Monkey
昨天

We recently compiled a list of the 10 Best Skincare Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against the other skincare stocks.

According to NielsenIQ, the global beauty market is expected to increase by 7.3% annually to reach $1 trillion in 2025, with Latin America by 19.1% and Africa-Middle East by 27.1% leading the way. Since TikTok Shop is the eighth-largest health and beauty shop in the US and generates around $1 billion in sales, e-commerce now accounts for 41% of US beauty sales. Nevertheless, 43% of customers believe that anti-theft methods like locked shelves discourage them from returning to a store. The fragrance and bath & shower segments drove the US beauty market’s 6.2% sales growth in 2024. Boomers choose product efficacy and anti-aging remedies, while Gen Z stresses skincare and values-driven companies. As a result, brands must implement data-driven generational strategies. To retain customer trust and relevance across changing demographics, successful beauty players will strike a balance between innovation and sustainability, integrating digital and physical shopping, and guaranteeing inclusivity and transparency.

On February 12, 2025, Circana reported that sales in the US beauty industry have increased for the fourth consecutive year. According to the report, mass-market beauty sales rose by 3% in 2024, while prestige beauty sales climbed 7% year over year to $33.9 billion. The fastest-growing prestige category was fragrance, which now accounts for 28% of prestige beauty sales and is the second-largest prestige category with double-digit unit growth and dollar sales up 12%. The growth rates for eau de parfums and parfums were 14% and 43%, respectively. Sales of high-end products surged by 12%, while sales of body sprays and hair fragrances jumped by 94% and 32%.

Specifically, skincare concluded the year as the slowest-growing category in the prestige market, with dollar sales up 2% and units expanding slightly faster—and a modest rise in both metrics in the mass market. Since top-performing masstige brands that are distributed across markets are propelling growth in both, skincare has emerged as the market that is best aligned across mass and prestige. Face cleansers and lip treatments were among the standout categories in the premium market. Body care products, such as lotions, creams, cleansers, and hand soaps, continued to outperform the facial market.

As per Circana’s report, the beauty industry continues to evolve as a result of the “skinification” of beauty, which involves incorporating skincare ingredients into body care, hair care, and makeup products. The first half of 2024 saw a 7% spike in U.S. skincare sales, with unit sales up 10% YoY. Body care and sun care are driving this growth, outpacing facial care as retinoids, AHAs, and vitamin C penetrate into these markets. Furthermore, this innovation drove double-digit growth in makeup sales, driven by serum foundations that give skin benefits and coverage and are packed with niacinamide, hyaluronic acid, and squalane. Hybrid makeup-skincare products are sought after by more than half of American consumers, with 60% of Gen Z and Millennials giving them top priority. Even the haircare industry has adopted skinification; salicylic and glycolic acids are popular for scalp care, and fragrance companies are experimenting with alcohol-free formulas to cater to sensitive skin. Brands must innovate and educate to remain competitive as consumers’ demands for multipurpose, benefit-driven products grow.

Larissa Jensen, global beauty industry advisor at Circana, stated:

“The beauty industry’s resilience continues to shine as consumers turn to beauty to not only look, but also feel good.” “With beauty products intertwined with consumers’ emotional needs and wellness routines, maximizing this opportunity will go a long way to ensure a healthy future for our industry.”

Looking ahead, according to Wendy Nicholson, managing director of Baird, commented:

“Skincare is one area where I think we’ll continue to see breakthroughs.”

She believes that when brands adapt to the change, consumer expenditure on injectibles and other treatments is likely to result in new product development.

An array of toothpaste, toothbrushes, and mouthwashes on a bright background, highlighting the company's oral care products.

Methodology:

We sifted through holdings of Beauty ETFs and online rankings to form an initial list of 20 skincare stocks.  From the resultant dataset, we chose 10 stocks with the highest number of hedge fund investors, using Insider Monkey’s database of 1,009 hedge funds in Q4 2024 to gauge hedge fund sentiment for stocks. We have used the stock’s Revenue Growth Rate (year-over-year) as a tie-breaker in case two or more stocks have the same number of hedge funds invested.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Colgate-Palmolive Company (NYSE:CL)

Number of Hedge Fund Investors: 62

One of the Best Beauty Stocks, Colgate-Palmolive Company (NYSE:CL), was established in 1806 and has since expanded to become a major force in the home and personal care industries. The company manufactures skincare products such as sunscreens. Moreover, the firm manufactures shampoos, shower gels, deodorants, and other homecare products that are delivered to more than 200 countries in addition to its renowned dental care line, which accounts for more than 40% of its total sales. Sales overseas account for about 70% of its total revenue, with developing countries accounting for 45% of this total.

In 2018, Colgate-Palmolive Company (NYSE:CL) began acquiring Filorga®, EltaMD®, and PCA SKIN® brands with the goal of creating a world-class, professionally recognized, and scientifically validated skin health company.

In 2024, Colgate-Palmolive Company (NYSE:CL) achieved net sales of over $20 billion for the first time, with organic sales growth of 7.4% across all product categories and divisions. The EPS of the business grew by double digits. While maintaining its global leadership in toothpaste (41.4% market share) and manual toothbrushes (32.2%), the company increased its gross profit margins. Operating cash flow was $4.1 billion, up 10% year over year, and was utilized to distribute $3.4 billion in dividends and stock buybacks to shareholders. The corporation raised marketing spending by 15% after growing it by 19% in 2023, showing the power and inventiveness of its brand.

Despite currency headwinds and the anticipated exit from private-label pet nutrition, Colgate-Palmolive Company (NYSE:CL) is still poised to sustain EPS growth in 2025 due to its high profit margins, strict cost control, and ongoing developments in digital and analytics.

Overall CL ranks 2nd on our list of the best skincare stocks to buy according to hedge funds. While we acknowledge the potential for CL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than CL but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

 

READ NEXT: 20 Best AI Stock To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

 

Disclosure: None. This article is originally published at Insider Monkey.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10